NeuroMetrix, Inc. (NASDAQ:NURO) headquartered in Waltham, will host a conference call for the investment community to discuss the 2Q20 earnings result on 23rd July 2020 at 8:00 AM Eastern Time.
Those interested in listening to the conference call live via the Internet can visit www.neurometrix.com
Earnings Expectation
NeuroMetrix, Inc. is reporting second quarter earnings results on Thursday 23rd July 2020, before market open.
NeuroMetrix, Inc., a healthcare company, develops and markets products for the detection, diagnosis, and monitoring of peripheral nerve and spinal cord disorders. The company develops wearable neuro-stimulation therapeutic devices and point-of-care neuropathy diagnostic tests to address chronic health conditions, including chronic pain, sleep disorders, and diabetes. Its marketed products include Quell, a wearable device for relief of chronic intractable pain, such as nerve pain due to diabetes and lower back problems; DPNCheck, a test used to evaluate systemic neuropathies, such as diabetic peripheral neuropathy; ADVANCE system, a platform for the performance of traditional nerve conduction studies; and SENSUS, a pain therapy device based on transcutaneous electrical nerve stimulation for relief of chronic intractable pain.
